Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRBP |
---|---|---|
09:32 ET | 7962 | 21.08 |
09:34 ET | 2285 | 20.94 |
09:36 ET | 2604 | 21.32 |
09:38 ET | 3434 | 21.01 |
09:39 ET | 8459 | 20.9768 |
09:41 ET | 9574 | 20.89 |
09:43 ET | 1565 | 20.8167 |
09:45 ET | 908 | 20.9 |
09:48 ET | 1440 | 21.0478 |
09:50 ET | 2535 | 21.47 |
09:52 ET | 3151 | 21.54 |
09:54 ET | 11913 | 21.93 |
09:56 ET | 10254 | 22.09 |
09:57 ET | 1890 | 21.9778 |
09:59 ET | 5543 | 21.77 |
10:01 ET | 12614 | 21.94 |
10:03 ET | 17552 | 22 |
10:06 ET | 2604 | 22 |
10:08 ET | 922 | 22 |
10:10 ET | 4840 | 21.92 |
10:12 ET | 1249 | 21.83 |
10:14 ET | 1912 | 21.95 |
10:15 ET | 1200 | 21.846 |
10:17 ET | 1500 | 21.82 |
10:19 ET | 7961 | 21.9369 |
10:21 ET | 15793 | 21.52 |
10:24 ET | 15548 | 21.85 |
10:26 ET | 2200 | 21.87 |
10:28 ET | 3142 | 21.79 |
10:30 ET | 28950 | 21.54 |
10:32 ET | 4459 | 21.455 |
10:33 ET | 2228 | 21.46 |
10:35 ET | 6620 | 21.02 |
10:37 ET | 2900 | 21.14 |
10:39 ET | 8033 | 21.045 |
10:42 ET | 5137 | 21.18 |
10:44 ET | 2645 | 21.08 |
10:46 ET | 2899 | 21.01 |
10:48 ET | 7612 | 20.95 |
10:50 ET | 7412 | 20.93 |
10:51 ET | 1000 | 21.02 |
10:53 ET | 986 | 21.01 |
10:55 ET | 12219 | 21.295 |
10:57 ET | 300 | 21.1145 |
11:00 ET | 100 | 21.1 |
11:02 ET | 1400 | 21.226 |
11:04 ET | 3700 | 21.11 |
11:06 ET | 7918 | 21 |
11:11 ET | 300 | 21.26 |
11:13 ET | 3649 | 21.11 |
11:15 ET | 600 | 21.12 |
11:18 ET | 1888 | 21.15 |
11:20 ET | 600 | 21.22 |
11:22 ET | 3616 | 21.3 |
11:24 ET | 5332 | 21.34 |
11:26 ET | 800 | 21.28 |
11:27 ET | 1936 | 21.34 |
11:29 ET | 3400 | 21.31 |
11:31 ET | 600 | 21.41 |
11:33 ET | 2085 | 21.5 |
11:36 ET | 4118 | 21.42 |
11:38 ET | 950 | 21.44 |
11:40 ET | 2700 | 21.39 |
11:42 ET | 200 | 21.37 |
11:44 ET | 100 | 21.42 |
11:45 ET | 400 | 21.43 |
11:47 ET | 100 | 21.37 |
11:49 ET | 500 | 21.37 |
11:51 ET | 1400 | 21.32 |
11:54 ET | 3909 | 21.43 |
11:56 ET | 2882 | 21.46 |
11:58 ET | 5949 | 21.61 |
12:00 ET | 2300 | 21.62 |
12:02 ET | 3800 | 21.535 |
12:03 ET | 16000 | 21.545 |
12:05 ET | 900 | 21.5 |
12:07 ET | 1850 | 21.5 |
12:09 ET | 2300 | 21.595 |
12:12 ET | 500 | 21.582 |
12:14 ET | 1015 | 21.55 |
12:16 ET | 1114 | 21.5 |
12:18 ET | 250 | 21.49 |
12:20 ET | 300 | 21.46 |
12:21 ET | 857 | 21.58 |
12:23 ET | 5177 | 21.53 |
12:25 ET | 1600 | 21.5347 |
12:27 ET | 2884 | 21.54 |
12:30 ET | 1500 | 21.53 |
12:32 ET | 4798 | 21.5 |
12:34 ET | 3764 | 21.45 |
12:36 ET | 3400 | 21.39 |
12:38 ET | 1842 | 21.42 |
12:39 ET | 589 | 21.335 |
12:41 ET | 3584 | 21.355 |
12:43 ET | 200 | 21.4699 |
12:48 ET | 163 | 21.32 |
12:52 ET | 100 | 21.3 |
12:54 ET | 400 | 21.2 |
12:56 ET | 400 | 21.32 |
12:57 ET | 8673 | 21.4 |
12:59 ET | 8724 | 21.44 |
01:01 ET | 4541 | 21.3693 |
01:03 ET | 700 | 21.385 |
01:06 ET | 300 | 21.39 |
01:08 ET | 200 | 21.425 |
01:10 ET | 1700 | 21.41 |
01:12 ET | 400 | 21.43 |
01:14 ET | 100 | 21.44 |
01:15 ET | 737 | 21.4 |
01:17 ET | 6195 | 21.415 |
01:19 ET | 11584 | 21.4099 |
01:21 ET | 600 | 21.33 |
01:26 ET | 5694 | 21.29 |
01:28 ET | 1200 | 21.25 |
01:30 ET | 4300 | 21.1039 |
01:32 ET | 5502 | 20.98 |
01:33 ET | 17937 | 21.05 |
01:35 ET | 682 | 21.15 |
01:37 ET | 2161 | 21.28 |
01:39 ET | 418 | 21.23 |
01:42 ET | 800 | 21.29 |
01:44 ET | 17070 | 21.155 |
01:46 ET | 300 | 21.07 |
01:48 ET | 960 | 21.16 |
01:50 ET | 1100 | 21.25 |
01:51 ET | 1406 | 21.39 |
01:53 ET | 3493 | 21.48 |
01:55 ET | 1100 | 21.505 |
01:57 ET | 820 | 21.52 |
02:00 ET | 1300 | 21.51 |
02:02 ET | 2169 | 21.495 |
02:04 ET | 702 | 21.560765 |
02:06 ET | 4742 | 21.46 |
02:08 ET | 564 | 21.48 |
02:09 ET | 588 | 21.5 |
02:11 ET | 500 | 21.5 |
02:13 ET | 2200 | 21.4903 |
02:15 ET | 600 | 21.58 |
02:18 ET | 100 | 21.4875 |
02:20 ET | 2500 | 21.5 |
02:22 ET | 2700 | 21.48 |
02:24 ET | 100 | 21.445 |
02:26 ET | 1598 | 21.5 |
02:27 ET | 1200 | 21.41 |
02:29 ET | 1900 | 21.405 |
02:31 ET | 100 | 21.49 |
02:33 ET | 500 | 21.28 |
02:38 ET | 500 | 21.27 |
02:40 ET | 700 | 21.35 |
02:42 ET | 1300 | 21.36 |
02:44 ET | 1000 | 21.35 |
02:45 ET | 600 | 21.35 |
02:47 ET | 1340 | 21.35 |
02:49 ET | 2800 | 21.51 |
02:51 ET | 600 | 21.44 |
02:54 ET | 301 | 21.49 |
02:56 ET | 3065 | 21.38 |
02:58 ET | 500 | 21.42 |
03:00 ET | 1741 | 21.49 |
03:02 ET | 16849 | 21.625 |
03:03 ET | 14518 | 21.62 |
03:05 ET | 2050 | 21.5633 |
03:07 ET | 22247 | 21.52 |
03:09 ET | 200 | 21.5 |
03:12 ET | 15881 | 21.51 |
03:14 ET | 5200 | 21.74 |
03:16 ET | 14104 | 21.666 |
03:18 ET | 9972 | 21.7125 |
03:20 ET | 12228 | 21.55 |
03:21 ET | 940 | 21.605 |
03:23 ET | 2615 | 21.615 |
03:25 ET | 1960 | 21.56 |
03:27 ET | 1250 | 21.55 |
03:30 ET | 1500 | 21.6 |
03:32 ET | 1546 | 21.57 |
03:34 ET | 5843 | 21.6025 |
03:36 ET | 1938 | 21.57 |
03:38 ET | 5532 | 21.54 |
03:39 ET | 19489 | 21.4 |
03:41 ET | 23813 | 21.36 |
03:43 ET | 2141 | 21.3 |
03:45 ET | 4546 | 21.19 |
03:48 ET | 5037 | 21.05 |
03:50 ET | 9161 | 21.09 |
03:52 ET | 13080 | 21.1143 |
03:54 ET | 3680 | 20.9806 |
03:56 ET | 6083 | 21.08 |
03:57 ET | 4213 | 21.0378 |
03:59 ET | 48080 | 20.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 672.2M | -3.6x | --- |
Humacyte Inc | 671.6M | -4.4x | --- |
Scholar Rock Holding Corp | 685.9M | -3.9x | --- |
Savara Inc | 691.3M | -9.8x | --- |
ProKidney Corp | 692.3M | -3.1x | --- |
Rapport Therapeutics Inc | 695.0M | -12.1x | --- |
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $672.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.55 |
EPS | $-5.82 |
Book Value | $-1.56 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.